Paula PerezSanchez
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Paula PerezSanchez researches the use of plants as biofactories for producing therapeutic proteins and antiviral compounds. Her work has explored the potential of genetically modified plants to generate compounds relevant to combating diseases such as COVID-19. She investigates strategies to enhance protein production in plant cell-based systems, addressing challenges in this area. A specific focus of her research involves the expression of enzymes, such as endoglucanase from Acidothermus cellulolyticus, in plants. This research examines post-translational modifications, like hydroxyproline-O-glycosylation, and their impact on the enzyme's function, including its effect on biomass digestibility. PerezSanchez also utilizes gene editing and biotechnology approaches in her studies.
Metrics
- h-index: 3
- Publications: 3
- Citations: 35
Selected Publications
-
Unlocking the full potential of plant cell-based production for valuable proteins: Challenges and innovative strategies (2025)
-
Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility (2024)
-
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19 (2023)
Collaboration Network
Top Collaborators
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Unlocking the full potential of plant cell-based production for valuable proteins: Challenges and innovative strategies
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Acidothermus cellulolyticus E1 endoglucanase expressed in planta undergoes extensive hydroxyproline-O-glycosylation and exhibits enhanced impact on biomass digestibility
- Unlocking the full potential of plant cell-based production for valuable proteins: Challenges and innovative strategies
Similar Researchers
Based on overlapping research topics